| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 264.324 | 86 |
| GSM780708 | Untreated after 4 days (C2_1) | 235.959 | 85 |
| GSM780709 | Untreated after 4 days (C3_1) | 298.077 | 87 |
| GSM780719 | Untreated after 4 days (C1_2) | 244.089 | 86 |
| GSM780720 | Untreated after 4 days (C2_2) | 226.58 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 243.353 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 192.315 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 244.706 | 86 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 215.088 | 84 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 199.36 | 84 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 245.206 | 86 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 214.845 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 328.522 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 264.451 | 86 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 231.042 | 85 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 344.692 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 237.154 | 85 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 247.336 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 202.47 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 250.479 | 86 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 232.589 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 219.894 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 229.104 | 85 |